Tilray | TRLY - Vertriebs- Und Verwaltungskosten





Vertriebs- Und Verwaltungskosten Veränderung Datum
Acasti Pharma USD 1.96M 180K 2025-09
Akebia Therapeutics USD 23.53M 3.19M 2025-12
Alaunos Therapeutics USD 447K 138K 2026-03
Aurora Cannabis CAD 40.62M 1.17M 2025-12
Avita Medical AUD 19.03M 1.95M 2025-12
Canopy Growth CAD 28.9M 636K 2025-12
Cronos Group USD 17.35M 2.1M 2026-03
Dianthus Therapeutics USD 6.57M 1.62M 2025-12
Divis Laboratories Ltd INR 3.4B 10M 2025-06
Ionis Pharmaceuticals USD 151M 21M 2026-03
IQVIA Holdings USD 502M 34M 2026-03
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Moderna USD 173M 135M 2026-03
Organigram Holdings CAD 7.73M 1.13M 2025-12
Organon & Co USD 433M 34M 2025-12
Revvity USD 253.88M 2.15M 2026-03
Tectonic Therapeutic USD 3.44M 1.52M 2025-12
Tilray USD 24.85M 1.7M 2025-09
Viatris USD 928.8M 101.9M 2026-03
Xeris Pharmaceuticals USD 42.64M 3.82M 2025-12
Zealand Pharma A/S 91.81M 99.04M 2025-12